BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20452237)

  • 41. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
    Wang Y; Zhang XR; Fu J; Tan W; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):369-72. PubMed ID: 15312350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
    Muley T; Fetz TH; Dienemann H; Hoffmann H; Herth FJ; Meister M; Ebert W
    Lung Cancer; 2008 Jun; 60(3):408-15. PubMed ID: 18083270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
    Rena O; Carsana L; Cristina S; Papalia E; Massera F; Errico L; Bozzola C; Casadio C
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):863-7. PubMed ID: 17936004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
    Zhu ZH; Sun BY; Ma Y; Shao JY; Long H; Zhang X; Fu JH; Zhang LJ; Su XD; Wu QL; Ling P; Chen M; Xie ZM; Hu Y; Rong TH
    J Clin Oncol; 2009 Mar; 27(7):1091-9. PubMed ID: 19188679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
    Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
    Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-small cell lung cancer with ipsilateral pulmonary metastases: prognosis analysis and staging assessment.
    Lee JG; Lee CY; Kim DJ; Chung KY; Park IK
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):480-4. PubMed ID: 18249000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Surgical treatment for stage III N2 non-small cell lung cancer].
    Wang S; Wu Y; Rong T; Huang Z; Ou W
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):605-7. PubMed ID: 12667337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A metabolomic approach to lung cancer.
    Hori S; Nishiumi S; Kobayashi K; Shinohara M; Hatakeyama Y; Kotani Y; Hatano N; Maniwa Y; Nishio W; Bamba T; Fukusaki E; Azuma T; Takenawa T; Nishimura Y; Yoshida M
    Lung Cancer; 2011 Nov; 74(2):284-92. PubMed ID: 21411176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Study of prognostic factors in patients with stage I non-small cell lung cancer].
    Ruan JZ; Duan Y; Qin M; Wang ZT
    Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(39):2767-9. PubMed ID: 21162914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Standards of practice: guidelines for thermal ablation of primary and secondary lung tumors.
    Pereira PL; Masala S;
    Cardiovasc Intervent Radiol; 2012 Apr; 35(2):247-54. PubMed ID: 22271076
    [No Abstract]   [Full Text] [Related]  

  • 51. [Prognostic value of the molecular markers ICAM-1 and C-JUN in patients with lung cancer].
    Uchikov A; Dimitrov I; Hadjiev B; Prisadov G; Uchikova E; Ganchevska P
    Khirurgiia (Sofiia); 2010; (1):36-9. PubMed ID: 21972703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sex as a prognostic factor for the patients with non-small cell lung cancer].
    Uchikov A; Dimitrov I; Uchikova E; Prisadov G; Grigorov D; Staribratova D; Novakov I
    Khirurgiia (Sofiia); 2009; (6):37-9. PubMed ID: 20506778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non-Small-Cell Lung Cancer.
    Rosell R; Wei J; Taron M
    Clin Lung Cancer; 2009 Jan; 10(1):8-9. PubMed ID: 19289365
    [No Abstract]   [Full Text] [Related]  

  • 54. Pleomorphic (sarcomatoid) carcinoma of lung--cytohistologic and immunohistochemical features.
    Zafar N; Johns CD
    Diagn Cytopathol; 2011 Feb; 39(2):115-6. PubMed ID: 20091900
    [No Abstract]   [Full Text] [Related]  

  • 55. [Non small cell lung cancer revealed by a solitary splenic metastasis of lung cancer].
    Oussama B; Makrem M; Neji FM; Amine L; Brahim K; Karim S; Sami B
    Tunis Med; 2013 Jul; 91(7):484-5. PubMed ID: 24008892
    [No Abstract]   [Full Text] [Related]  

  • 56. ["A priori" resectability of NSCLC pulmonary neoplasms in relation to the new international classification].
    Radermecker MA; Ghaye B; Dekoster G; Limet R
    Rev Med Liege; 1995 Jun; 50(6):264-7. PubMed ID: 7618005
    [No Abstract]   [Full Text] [Related]  

  • 57. Breast metastasis in a male patient with nonsmall cell lung carcinoma.
    Ucar N; Kurt OK; Alpar S; Orsel O; Demirag F; Kurt B
    South Med J; 2007 Aug; 100(8):850-1. PubMed ID: 17715476
    [No Abstract]   [Full Text] [Related]  

  • 58. Diagnostic and staging procedures in non-small cell lung cancer.
    Ginsberg RJ; Schmocker B
    Curr Opin Oncol; 1990 Apr; 2(2):328-30. PubMed ID: 1965628
    [No Abstract]   [Full Text] [Related]  

  • 59. Lingual metastasis as the initial presentation of a large cell lung carcinoma.
    Mui S; Smith AE
    Otolaryngol Head Neck Surg; 1999 Sep; 121(3):305-6. PubMed ID: 10471881
    [No Abstract]   [Full Text] [Related]  

  • 60. [A study of postoperative prognosis of lung cancer with special reference to clinical and pathological observations].
    Kato T
    Zasshi Tokyo Ika Daigaku; 1970 Sep; 28(5):795-814. PubMed ID: 5535748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.